From: Nuclear receptor coregulator SNP discovery and impact on breast cancer risk
SNP | Genotypes | Cases | Controls | OR | 95% CI | P |
---|---|---|---|---|---|---|
SRC-1 | CC (%) | 1147 (94.2) | 1432 (94.9) | 1 | Â | Â |
rs1804645 | CT (%) | 69 (5.6) | 77 (5.1) | 1.11 | 0.80-1.56 | 0.510 |
P1272S | TT (%) | 2 (0.2) | 0 (0.0) | - | - | - |
 |  | [CT + TT]<-> [CC] | 1.15 | 0.82-1.60 | 0.405 | |
SRC-3 | CC (%) | 1089 (89.9) | 1330 (89.3) | 1 | Â | Â |
rs6094752 | CT (%) | 116 (9.6) | 152 (10.2) | 0.93 | 0.72-1.20 | 0.587 |
C218R | TT (%) | 6 (0.5) | 8 (0.5) | 0.92 | 0.32-2.65 | 0.871 |
 |  | [CT + TT]<-> [CC] | 0.93 | 0.73-1.19 | 0.575 | |
SRC-3 | GG (%) | 988 (80.8) | 1207 (80.3) | 1 | Â | Â |
rs2230782 | CG (%) | 226 (18.5) | 272 (18.1) | 1.11 | 0.83-1.23 | 0.881 |
Q586H | CC (%) | 9 (0.7) | 24 (1.6) | 0.46 | 0.21-0.99 | 0.042 |
 |  | [CC]<-> [GG + GC] | 0.45* | 0.21-0.98* | 0.041* | |
SRC-3 | AA (%) | 1011 (82.7) | 1240 (82.2) | 1 | Â | Â |
rs2076546 | AG (%) | 202 (16.5) | 249 (16.5) | 0.99 | 0.25-1.22 | 0.961 |
T960T | GG (%) | 9 (0.8) | 20 (1.3) | 0.55 | 0.25-1.22 | 0.135 |
 |  | [AG + GG]<-> [AA] | 0.96° | 0.79-1.17° | 0.702° | |
SMRT | GG (%) | 789 (66.2) | 1004 (67.6) | 1 | Â | Â |
rs2229840 | AG (%) | 357 (30.0) | 423 (28.5) | 1.07 | 0.91-1.27 | 0.407 |
A1706T | AA (%) | 45 (3.8) | 57 (3.9) | 1.01 | 0.67-1.50 | 0.982 |
 |  | [AG + GG]<-> [AA] | 1.06 | 0.91-1.25 | 0.441 |